January 26, 2016
Track this case
Nathaniel M. Gorton
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.Additional or older documents may be available in Pacer.
Momenta Pharmaceuticals Inc. and Sandoz Inc. cannot ask the First Circuit to opine on the validity of an antitrust case against them because the generic-drug companies’ legal questions are inseparable from factual ones, a federal judge ruled Friday.
Already a subscriber? Click here to login